Metformin Associated Lactic Acidosis: a Case Report and Literatures Review
Article Sidebar
Main Article Content
Abstract
Metformin is a widely used oral hypoglycemic agent. Lactic acidosis is serious side effect but rare. Risk factors of this condition are mostly contraindication of metformin therapy. Because only few cases have been reported in Thailand, General practitioners may lack of experience and unaware of this side effect. This report presented a case of suspected metformin associated lactic acidosis and literatures review.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Cohen RD, Woods HF. Clinical and Biochemical Aspects of Lactic Acidosis. 1st ed. Oxford: Blackwell Scientic Publications; 1976.
Kimmel B, Inzucchi SE. Oral agents for type 2 Diabetes: An update. Clinical Diabetes 2005; 23:64-76.
DeFronzo RA, Gooodman AM. Efficacy of metformin in pattents with non-insulin-dependent diabetes mellitus. N Eng J Med 1995; 333: 541-9.
U.K. Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1988; 352: 854-65.
Knowler WC, Barrett-Conner E, Fower SE, Hamman RF, Lachin JM, Walker EA, et al. DM, the DPP Rescarch Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng Med 2002; 346: 393-403.
Jones GC, Macklin JP, Alexander W D.Contraindica- tions to the use of metformin. BMJ 2003;326:4-5.
Misbin RI, Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann Intern Med 1977; 87: 591-5.
Bailey CJ. Biguanides and NIDDM. Diabetes Care 1992; 15:755-72.
Stang M, Wysowski DK, Butler-Jones Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22:925-7.
Bailey CJ, Turner RC. Metformin. N Engl Med 1996; 334: 574-9.
Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163:2594-602.
Dawson D, Conlon C. Case study: Metformin-associated lactic acidosis. Diabetes Care 2003; 26:2471-2.
Gudmundsdottir H, Aksnes H, Heldal K, Krogh A, Froyshot S, Rudberg N, et al. Metformin and antihyper~ tensive therapy with drugs blocking the renin angiotensin system, a cause of concem? Clim Nephrol 2006; 66:380-5
Stades AME, Heikens JT, Erkelens DW, Holleman F, Hoekstra JBL. Metformin and lactic acidosis: cause or coincidence? A review of case reports. I of Intem Med 2004; 255: 179-87.
Adrogue HJ, Madias NE. Management of life-reatening acid-base disorders-First of two parts. NEngl J Med 1998; 338: 26-34.
Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, et al. A controlled trial of dichloroacetate for the treatment of lactic acidosis in adults. N Engl J Med 1992; 327: 1564-9.
Teale KFH, Devine A, Stewart H, Harper NJH. The management of metformin overdose. Anaesthesia 1998; 53:691-701.
Barrueto F, Meggs W, Barchman MJ. Clearance of metformin by hemofiltration in overdose. Toxicol Clin Toxicol 2002; 40: 177.
Lalau JD, Race JM. Lactic Acidosis in MetforminTreated Patients: Prognostic Value of Arterial lactate levels and Plasma Metformin concentrations. Drug Safety 1999;20:377-84.
Korbonen T,Idanpaan-Heikkila J,Aro A.Biguanide associated lactic acidosis in Finland. Eur I Clin Pharmacol 1979; 15: 407-10.